SightfileU.S. market data from official filings

Companies › ACON

ACLARION INC (ACON)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001635077 · EDGAR filings · Updated 2026-07-09

ACLARION INC (ACON) has reported institutional ownership of 4.9%, with 10 institutional managers holding positions valued at $368.1K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
4.9%
Institutional managers
10
Reported 13F value
$368.1K
Insider activity
1 trans.
$62 net buying
Data flags
3 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ACLARION INC has 10 institutional holders and institutional ownership of 4.9%.

Insider activity

Insiders reported 1 transactions (1 buys, 0 sells) across 1 reporting insiders, with a net reported value of $62.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2025-04-09 (recurring since 2022-06-06) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2024-10-11 (recurring since 2022-04-27) — source filing. The authoritative details are those stated in the filing itself.
Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2023-05-23 (recurring since 2023-05-16) — source filing. The authoritative details are those stated in the filing itself.

Related companies

SILO PHARMA INC (SILO) · NEXALIN TECHNOLOGY INC (NXL) · MUSTANG BIO INC (MBIO) · Aspire Biopharma Holdings Inc (ASBP) · ALAUNOS THERAPEUTICS INC (TCRT) · CNS PHARMACEUTICALS INC (CNSP)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.